Surgical Innovations Group SUN.L · GBp

Its shares trade on LSE under the ticker SUN.L. It has been listed since 7 July 1998. In the fiscal year to 31 December 2025, it reported revenue of £11.6m and a net loss of £895,000. At that date it held total assets of £11.6m and shareholders' equity of £7.6m.

Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. The firm sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The firm operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of minimally invasive technology products for PE applications.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Gordon DavisNon-Executive Chairman of the Board
• Mr. David MarshChief Executive Officer, Executive Director, since 2017£234,000
• Mr. Brent GreethamChief Financial Officer, Company Secretary, Executive Director, since 2025
• Mr. Stephen SeedChief Compliance Officer, since 2022
• Ms. Julia Horrocks-taylorHuman Resource Director
• Mr. Charles SoukupNon-Executive Director
• Mr. Andrew BotelerNon-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.